LFG
ADPT icon

Larson Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History

Larson Financial Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59K Buy
74
+9
+14% +$138 ﹤0.01% 3183
2026
Q1 		$902 Sell
65
-146
-69% -$2.33K ﹤0.01% 3189
2025
Q4 		$3.43K Buy
211
+141
+201% +$2.3K ﹤0.01% 2612
2025
Q3 		$1.05K Buy
+70
New +$853 ﹤0.01% 2908

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Larson Financial Group's ADPT Position: Q2 2026 in Review

Larson Financial Group increased its Adaptive Biotechnologies (ADPT) stake by 14% in Q2 2026, buying an estimated $138 and bringing the position to 74 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #3183.

Larson Financial Group first reported a position in ADPT in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.43K in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Larson Financial Group held 74 shares of Adaptive Biotechnologies worth $1.59K as of Q2 2026.
  • Larson Financial Group bought 9 Adaptive Biotechnologies shares in Q2 2026, an estimated $138.
  • Adaptive Biotechnologies made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3183 holding.
  • Larson Financial Group first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 4 quarters since.
  • Larson Financial Group's Adaptive Biotechnologies position peaked at $3.43K in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.